NATIONAL ALLIANCE FOR CARE AT HOME

Lobbying client · Virginia · filed 2025 to 2026

Trade association

$340,000 Reported spend

7 Filings counted

1 Firms hired

1 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page is grouped by the client's LDA id (65781), not by name.

Firms hired 1

FEDERAL HEALTH POLICY STRATEGIES $340,000 7 filings

Bills named in these filings 1

HR 5142
Home Health Stabilization Act of 2025

2 filings

Reported by year 2 years

2026 $120,000 2 filings
2025 $220,000 5 filings

Issues lobbied 1

Medicare/Medicaid 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

Health & Human Services, Dept of (HHS) 6
HOUSE OF REPRESENTATIVES 6
SENATE 6
Executive Office of the President (EOP) 2
Office of Management & Budget (OMB) 1

Recent filings 7 total

Q2

FEDERAL HEALTH POLICY STRATEGIES

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 20, 2026

View → Q1

FEDERAL HEALTH POLICY STRATEGIES

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 20, 2026

View → Q4

FEDERAL HEALTH POLICY STRATEGIES

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Jan 20, 2026

View → Q3

FEDERAL HEALTH POLICY STRATEGIES

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $60,000 income · posted Oct 20, 2025

View → Q2

FEDERAL HEALTH POLICY STRATEGIES

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $60,000 income · posted Jul 21, 2025

View → Q1

FEDERAL HEALTH POLICY STRATEGIES

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $40,000 income · posted Apr 18, 2025

View → RR

FEDERAL HEALTH POLICY STRATEGIES

1st Quarter (Jan 1 - Mar 31) 2025 · posted Apr 15, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.